Skip to main content
SpringerLink
Log in

New systemic therapy for breast cancer

  • Published:
Breast Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

AC:

Adriamycin (doxorubicin), cyclophosphamide

CHF:

Congestive heart failure

CMF:

Cyclophosphamide, methotrexate, fluorouracil

FAC:

Fluorouracil, adriamycin, cyclophosphamide

Author information

Authors and Affiliations

  1. Centre René Gauducheau, Nantes, France

    Pierre Fumoleau, Dominique Berton-Rigaud, Valerie Delecroix, Franck Priou & Stephanie Bordenave

Authors
  1. Pierre Fumoleau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominique Berton-Rigaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valerie Delecroix
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Franck Priou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephanie Bordenave
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Fumoleau, P., Berton-Rigaud, D., Delecroix, V. et al. New systemic therapy for breast cancer. Breast Cancer 6, 382–385 (1999). https://doi.org/10.1007/BF02966459

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02966459

Key words

Search

Navigation